1. What specific clinical and laboratory criteria are used to diagnose influenza-associated meningitis, and how do these criteria differentiate it from other types of meningitis?
2. In the context of Ms. Rodriguez's diagnosis, what other conditions should be considered in the differential diagnosis, and what key features help distinguish influenza-associated meningitis from these conditions?
3. What potential complications can arise from influenza-associated meningitis, and how should these be monitored and managed in Ms. Rodriguez's case?
4. How does the confirmation of influenza virus RNA in the cerebrospinal fluid via PCR testing contribute to the certainty of the diagnosis, and what additional tests, if any, could further support this diagnosis?
5. Considering the diagnosis and treatment plan, what factors should be considered to ensure effective management and prevent further complications or spread of the infection within the hospital setting?